Dapagliflozin versus sulfonylurea as an add-on therapy to metformin- A cost-effectiveness analysis in Colombia
May 1, 2014, 00:00 AM
10.1016/j.jval.2014.03.1442
https://www.valueinhealthjournal.com/article/S1098-3015(14)01493-4/fulltext
Section Title :
Diabetes/Endocrine Disorders I
Section Order :
917
First Page :
A247
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)01493-4&doi=10.1016/j.jval.2014.03.1442